Proventa International will accumulate more than 100 C-Level Directors from a blend of rising to substantial Pharmaceutical, Biotechnology and Academic/Research Institutions to help understand their key vital difficulties in the zone of Oncology. Enroll now and Book your seat. Constrained openings as it were.
The Oncology Roundtable Discussions Strategy Meeting are for qualified end-clients. These incorporate Senior Executives of Oncology/Immuno-Oncology (from medium to substantial Pharma, Biopharma and Biotech players) in worldwide improvement positions spreading over early advancement to stage IV, and also thought pioneers from Academia and administrative experts.
Thought pioneers who will profit by going to incorporate CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads in charge of:
– Oncology R&D,Translational Research/Development/Medicine, Clinical Research/Development, Immuno-Oncology, Medical Affairs Oncology,Clinical Pharmacology,Oncology Clinical Biostatistics and Programming, Oncology Clinical Genomics and Computational Biology, Oncology R&D Innovation, Oncology R&D Strategy, Oncology Portfolio/Project Management.
Post A Comment:
0 comments so far,add yours